The Nordic EMBL Partnership for Molecular Medicine is dedicated to research excellence in molecular medicine, and life science research that investigates the molecular basis of disease and explores molecular and genetic based treatments. Each institute brings a unique set of expertise, skills, and facilities together with the recognised research strengths of the EMBL. The Partnership provides access to scientific infrastructure as well as clinical materials, networks, and training activities and adopts the EMBL model for international recruitment and scientific reviews. Find out more

PhD positions at DANDRITE are advertised through general open calls with application deadlines four times every year in February, May, August/September, and November. Find more details at DANDRITE web.